EUVIMEDEUVIMED entdecken
Open Access

Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer

Cathryn Crockett iD, James Price, Mai Pham, Danya Abdulwahid, Neil Bayman, Fiona Blackhall, Layla Bostock, Raffaele Califano, Clara Chan, Joanna Coote iD, Laura Cove-Smith, Marie Eaton und 15 weitere

JCO Clinical Cancer Informatics · 2023

DOI: 10.1200/cci.22.00150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2023. Verfasst von Cathryn Crockett und 26 weiteren Autor:innen. Beteiligte Einrichtung: Northern Ireland Cancer Centre, Belfast, United Kingdom. Hauptthemen laut MEDLINE: Quality of Life, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE The Christie NHS Foundation Trust launched their electronic patient-reported outcome measures (ePROMs) service in January 2019 in the routine clinical setting. The lung cancer questionnaires consist of 14 symptom items, adapted from the Common Terminology Criteria for Adverse Events (version 5.0) and the EuroQol EQ-5D-5L quality-of-life (QoL) tool. Patients with lung cancer are invited to complete questionnaires assessing their symptoms and QoL using an online platform. METHODS The ePROM responses and clinical, pathologic, and treatment data for patients who completed the questionnaires between January 2019 and December 2020 were extracted from electronic medical records. The symptom and QoL scores of patients who completed baseline pretreatment ePROMs and also those who completed ePROMs pre- and postpalliative lung systemic anticancer therapy (SACT) or radical thoracic radiotherapy were evaluated. Pretreatment questionnaires were analyzed according to age, Eastern Cooperative Oncology Group performance status (ECOG PS), and Adult Comorbidity Evaluation-27 (ACE-27) comorbidity score. RESULTS One thousand four hundred eighty patients with lung cancer were included. There were no statistically significant differences in symptoms and QoL scores between age groups. Cough ( P = .006) and EQ-5D-5L mobility scores ( P = .006) were significantly worse for patients with an ECOG PS of 0-1. Dyspnea ( P = .035), hemoptysis ( P = .023), nausea ( P = .041), mobility ( P = .004), and self-care ( P = .0420) were significantly worse for those with higher ACE-27 scores (2-3 v 0-1). Palliative SACT was associated with a significant improvement in cough ( P < .001) and hemoptysis ( P = .025), but significantly negatively affected mobility ( P = .013). Patients receiving radical thoracic radiotherapy reported a significant improvement in hemoptysis ( P = .042) but worse pain ( P = .002) and fatigue ( P = .01). Other changes in symptom and QoL scores were not significant. CONCLUSION The symptoms and QoL reported at baseline and before and after both palliative SACT and radical thoracic radiotherapy are clinically relevant and meaningful. We have demonstrated that routine implementation of ePROMs into clinical practice is feasible and can inform clinical practice and future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeLung NeoplasmsAdultHumansCoughHemoptysisPatient Reported Outcome Measures

Autor:innen und Institutionen

  • Northern Ireland Cancer Centre, Belfast, United Kingdom.
  • The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • Christie Patient-Centred Research, Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, United Kingdom.

ORCID-Profile: Cathryn Crockett, Joanna Coote, Fabio Gomes, Margaret Harris, Colin Lindsay, Laura Pemberton, Corinne Faivre-Finn

Zitieren

APA

Crockett, C., Price, J., Pham, M., Abdulwahid, D., Bayman, N., Blackhall, F., Bostock, L., Califano, R., Chan, C., Coote, J., Cove-Smith, L., Eaton, M., Fenemore, J., Gomes, F., Harris, M., Halkyard, E., Hughes, S., Lindsay, C., Neal, H., …, & Faivre-Finn, C. (2023). Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.22.00150

Vancouver

Crockett C, Price J, Pham M, Abdulwahid D, Bayman N, Blackhall F, et al. Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer. JCO Clinical Cancer Informatics. 2023. doi:10.1200/cci.22.00150

BibTeX
@article{Crockett2023,
  author = {Crockett, Cathryn and Price, James and Pham, Mai and Abdulwahid, Danya and Bayman, Neil and Blackhall, Fiona and Bostock, Layla and Califano, Raffaele and Chan, Clara and Coote, Joanna and Cove-Smith, Laura and Eaton, Marie and Fenemore, Jacqueline and Gomes, Fabio and Harris, Margaret and Halkyard, Emma and Hughes, Sarah and Lindsay, Colin and Neal, Hilary and McEntee, Delyth and Pemberton, Laura and Sheikh, Hamid and Summers, Yvonne and Taylor, Paul and Woolf, David and Yorke, Janelle and Faivre-Finn, Corinne},
  title = {Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer},
  journal = {JCO Clinical Cancer Informatics},
  year = {2023},
  doi = {10.1200/cci.22.00150}
}
Kostenlos starten →